These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

682 related items for PubMed ID: 18582632

  • 1. Marked impairment of protease-activated receptor type 1-mediated vasodilation and fibrinolysis in cigarette smokers: smoking, thrombin, and vascular responses in vivo.
    Lang NN, Gudmundsdóttir IJ, Boon NA, Ludlam CA, Fox KA, Newby DE.
    J Am Coll Cardiol; 2008 Jul 01; 52(1):33-9. PubMed ID: 18582632
    [Abstract] [Full Text] [Related]

  • 2. Role of the endothelium in the vascular effects of the thrombin receptor (protease-activated receptor type 1) in humans.
    Gudmundsdóttir IJ, Lang NN, Boon NA, Ludlam CA, Webb DJ, Fox KA, Newby DE.
    J Am Coll Cardiol; 2008 May 06; 51(18):1749-56. PubMed ID: 18452780
    [Abstract] [Full Text] [Related]

  • 3. Direct vascular effects of protease-activated receptor type 1 agonism in vivo in humans.
    Gudmundsdóttir IJ, Megson IL, Kell JS, Ludlam CA, Fox KA, Webb DJ, Newby DE.
    Circulation; 2006 Oct 10; 114(15):1625-32. PubMed ID: 17015787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute effects of glucocorticoids on endothelial fibrinolytic and vasodilator function in humans.
    Dover AR, Hadoke PW, Walker BR, Newby DE.
    J Cardiovasc Pharmacol; 2007 Sep 10; 50(3):321-6. PubMed ID: 17878762
    [Abstract] [Full Text] [Related]

  • 6. Acute endothelial tissue plasminogen activator release in pregnancy.
    Robb AO, Mills NL, Din JN, Cameron S, Ludlam CA, Newby DE, Denison FC.
    J Thromb Haemost; 2009 Jan 10; 7(1):138-42. PubMed ID: 18983502
    [Abstract] [Full Text] [Related]

  • 7. B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
    Cruden NL, Tse GH, Fox KA, Ludlam CA, Megson I, Newby DE.
    Arterioscler Thromb Vasc Biol; 2005 Apr 10; 25(4):772-7. PubMed ID: 15681300
    [Abstract] [Full Text] [Related]

  • 8. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW, Helmy A, Ludlam C, Webb DJ, Hayes PC, Newby DC.
    Thromb Res; 2008 Apr 10; 121(5):675-80. PubMed ID: 17870147
    [Abstract] [Full Text] [Related]

  • 9. Bradykinin receptor antagonism and endothelial tissue plasminogen activator release in humans.
    Witherow FN, Dawson P, Ludlam CA, Webb DJ, Fox KA, Newby DE.
    Arterioscler Thromb Vasc Biol; 2003 Sep 01; 23(9):1667-70. PubMed ID: 12869356
    [Abstract] [Full Text] [Related]

  • 10. Influence of oral contraceptive use on endothelial t-PA release in healthy premenopausal women.
    Hoetzer GL, Stauffer BL, Greiner JJ, Casas Y, Smith DT, DeSouza CA.
    Am J Physiol Endocrinol Metab; 2003 Jan 01; 284(1):E90-5. PubMed ID: 12388132
    [Abstract] [Full Text] [Related]

  • 11. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD, Dawson P, Ludlam CA, Boon NA, Newby DE.
    Clin Sci (Lond); 2006 Mar 01; 110(3):353-60. PubMed ID: 16309383
    [Abstract] [Full Text] [Related]

  • 12. Effect of ω-3 fatty acid supplementation on endothelial function, endogenous fibrinolysis and platelet activation in male cigarette smokers.
    Din JN, Archer RM, Harding SA, Sarma J, Lyall K, Flapan AD, Newby DE.
    Heart; 2013 Feb 01; 99(3):168-74. PubMed ID: 23184014
    [Abstract] [Full Text] [Related]

  • 13. Bradykinin and its metabolite bradykinin 1-5 inhibit thrombin-induced platelet aggregation in humans.
    Murphey LJ, Malave HA, Petro J, Biaggioni I, Byrne DW, Vaughan DE, Luther JM, Pretorius M, Brown NJ.
    J Pharmacol Exp Ther; 2006 Sep 01; 318(3):1287-92. PubMed ID: 16772538
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction.
    Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, Webb DJ.
    Circulation; 1999 Mar 23; 99(11):1411-5. PubMed ID: 10086962
    [Abstract] [Full Text] [Related]

  • 16. Release of tissue-type plasminogen activator in response to muscarinic receptor stimulation in human forearm.
    Jern S, Selin L, Bergbrant A, Jern C.
    Thromb Haemost; 1994 Oct 23; 72(4):588-94. PubMed ID: 7878638
    [Abstract] [Full Text] [Related]

  • 17. An in vivo model for the assessment of acute fibrinolytic capacity of the endothelium.
    Newby DE, Wright RA, Ludlam CA, Fox KA, Boon NA, Webb DJ.
    Thromb Haemost; 1997 Oct 23; 78(4):1242-8. PubMed ID: 9364992
    [Abstract] [Full Text] [Related]

  • 18. Effects of acute methionine loading and vitamin C on endogenous fibrinolysis, endothelium-dependent vasomotion and platelet aggregation.
    Labinjoh C, Newby DE, Wilkinson IB, Megson IL, MacCallum H, Melville V, Boon NA, Webb DJ.
    Clin Sci (Lond); 2001 Feb 23; 100(2):127-35. PubMed ID: 11171280
    [Abstract] [Full Text] [Related]

  • 19. Tissue plasminogen activator genetic polymorphisms do not influence tissue plasminogen activator release in patients with coronary heart disease.
    Robinson SD, Ludlam CA, Boon NA, Newby DE.
    J Thromb Haemost; 2006 Oct 23; 4(10):2262-9. PubMed ID: 16836660
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin-converting enzyme inhibition improves venous endothelial dysfunction in chronic smokers.
    Chalon S, Moreno H, Hoffman BB, Blaschke TF.
    Clin Pharmacol Ther; 1999 Mar 23; 65(3):295-303. PubMed ID: 10096262
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.